Evidence map›Paper›PMID 38002656›Full record

ReviewJournal of clinical medicine2023

Endocarditis after Transcatheter Aortic Valve Replacement.

Lorenzo Braghieri, Simrat Kaur, Christopher K Black, Paul C Cremer, Shinya Unai, Samir R Kapadia, Amgad Mentias

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lorenzo BraghieriDepartment of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Simrat KaurHeart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Christopher K BlackDepartment of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Paul C CremerHeart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Shinya UnaiHeart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Samir R KapadiaHeart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Amgad MentiasHeart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.ORCID 0000-0001-6555-2517
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter aortic valve replacement (TAVR) use is gaining momentum as the mainstay for the treatment of aortic stenosis compared to surgical aortic valve replacement (SAVR). Unfortunately, TAVR-related infective endocarditis (TAVR-IE) is expected to be detected more and more as a result of the ever-expanding indications in younger patients. Given the overall poor prognosis of TAVR-IE, it is imperative that clinicians familiarize themselves with common presentations, major risk factors, diagnostic pitfalls, therapeutic approaches, and the prevention of TAVR-IE. Herein, we review all of the above in detail with the most updated available literature.

Indexed as

aortic valve replacementinfective endocarditisSAVRTAVRtranscatheter aortic valve replacement

Identifiers

PMID38002656
PMCPMC10672470
OpenAlexW4388634018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.